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Potassium channelHuman T cell leukemia virus type 1 (HTLV-1) encodes p13, an 87-amino-acid protein that accumulates in the
inner mitochondrial membrane. Recent studies performed using synthetic p13 and isolated mitochondria
demonstrated that the protein triggers an inward potassium (K+) current and inner membrane
depolarization. The present study investigated the effects of p13 on mitochondrial inner membrane
potential (Δψ) in living cells. Using the potential-dependent probe tetramethyl rhodamine methyl ester
(TMRM), we observed that p13 induced dose-dependent mitochondrial depolarization in HeLa cells. This
effect was abolished upon mutation of 4 arginines in p13's α-helical domain that were previously shown to
be essential for its activity in in vitro assays. As Δψ is known to control mitochondrial calcium (Ca2+) uptake,
we next analyzed the effect of p13 on Ca2+ homeostasis. Experiments carried out in HeLa cells expressing
p13 and organelle-targeted aequorins revealed that the protein speciﬁcally reduced mitochondrial Ca2+
uptake. These observations suggest that p13 might control key processes regulated through Ca2+ signaling
such as activation and death of T cells, the major targets of HTLV-1 infection.ncologiche e Chirurgiche, Via
5885; fax: +39 049 807 2854.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Human T cell leukemia virus type 1 (HTLV-1) is a retrovirus that
infects 10–20 million people worldwide. Although most persons
infected with HTLV-1 remain life-long asymptomatic carriers, about
3–5% eventually develop adult T cell leukemia/lymphoma (ATLL), an
aggressive neoplasm of mature CD4+ T cells, or tropical spastic
paraparesis/HTLV-associated myelopathy (TSP/HAM), a progressive
demyelinating disease that mainly targets the thoracic spinal cord
[1,2].
In addition to the gag, pol, and env genes found in all retroviruses,
the HTLV-1 genome contains other open reading frames coding for
the regulatory proteins Tax and Rex, both of which are essential for
viral replication, and accessory proteins named p12, p21, p30, HBZ,
and p13 [3]. Detailed studies of the oncogenic potential of HTLV-1
have identiﬁed Tax as a major factor driving transformation. In
addition to activating transcription from the viral promoter, Tax
affects the expression of cellular genes controlling cell proliferation,
apoptosis, and chromosomal stability and is sufﬁcient for immortal-ization of T cells [4]. However, the low prevalence and long latency of
ATLL (usually several decades from infection to diagnosis) indicate
that additional viral and cellular factors must inﬂuence the
balance between persistent, disease-free infection and Tax-driven
leukemogenesis.
The present study is focused on the viral accessory protein p13.
Initial studies of p13 demonstrated that it accumulates in mitochon-
dria and disrupts mitochondrial morphology, resulting in isolated
clusters of round-shaped, apparently swollen mitochondria, some of
which form ring-like structures [5,6]. Cells expressing p13 exhibit
reduced proliferation rates and increased sensitivity to apoptosis
triggered by ceramide and FasL [7,8]. p13 also interferes with the
ability of HeLa cells and Ras/Myc-transformed primary ﬁbroblasts to
grow as tumors in nude mice, suggesting that it may exert tumor-
suppressor-like activity [8].
Immunoelectron microscopy and fractionation experiments dem-
onstrated that p13 is an integral membrane protein and accumulates
mainly in the inner mitochondrial membrane [9]. Its 87-amino-acid
sequence includes a mitochondrial targeting signal (MTS) spanning
amino acids 21–31 [5] that contains 4 arginines. Although p13
mutants carrying substitutions of the arginines with glutamines,
prolines, or alanines and leucines retain mitochondrial targeting, they
produce little or no mitochondrial fragmentation/swelling, indicating
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(LRVWRLCTRRL) is predicted to form an α-helix, with the 4 arginines
forming a positively charged face, thereby imparting amphipathic
properties to this region [9]. Biophysical and biochemical analyses of a
synthetic peptide spanning residues 9–41 (p139–41) conﬁrmed that
this region folds into an amphipathic α-helix upon exposure to
membrane-mimetic solutions [9]. Initial in vitro assays carried out
using isolated rat liver mitochondria and p139–41 demonstrated that
the peptide induced energy-dependent swelling that depended on K+
and mitochondrial inner membrane potential (Δψ). These effects
were evident when the peptidewas used in the lowmicromolar range
and required the presence of the critical arginine residues [9]. More
recent analyses of full-length synthetic p13 revealed that it is at least
10-fold more potent than p139–41 in changing K+ permeability in
isolated mitochondria. In these assays, p13 induced an inﬂux of K+
into the mitochondrial matrix; this effect was evident using as little as
50–100 nM of the protein and was lost upon collapse of Δψ with
carbonylcyanide p-triﬂuoromethoxyphenylhydrazone (FCCP). In-
creased K+ permeability was accompanied by a dose-dependent
reduction in Δψ. In addition, the protein induced an increase in
respiratory chain activity, which partially masked its effects on Δψ
while augmenting production of reactive oxygen species (ROS). The
protein also reduced the threshold for permeability transition pore
(PTP) opening [10]. The effects of p13 on Δψ, respiratory chain
activity, ROS production, and sensitization to PTP opening were
evident at doses of 100–200 nM. The present study extends these in
vitro ﬁndings by testing the effects of p13 on Δψ in living cells. Results
conﬁrm that p13 exerts a dose-dependent effect on Δψ leading to a
reduction in mitochondrial Ca2+ uptake.
2. Materials and methods
2.1. Plasmids
Plasmid pSGp13, expressing p13 under the control of the SV40
promoter, and derivatives in which arginines at positions 22, 25, 29,
and 30 were mutated either to glutamines (pSGp13RQ), alanine–
leucine–leucine–alanine (pSGp13RAL), or prolines (pSGp13RP), were
previously described [9]. pcDNAp13–GFP, expressing p13 fused to
enhanced green ﬂuorescent protein, was constructed by inserting the
fused gene into the CMV promoter-driven vector pcDNA3.1 (Invitro-
gen). pcDNAp13RQ–GFP, containing glutamines instead of arginines
as described for pSGp13, was generated by PCR-based plasmid
mutagenesis (Quikchange, Stratagene). Plasmids expressing chimeric
aequorins targeted to mitochondria (mtAEQmut), the cytosol
(cytAEQ), and the endoplasmic reticulum (ER; erAEQmut) were
previously described [11]; “AEQ” refers to wild-type aequorin, and
“AEQmut” refers to a low-afﬁnity D119A mutant of aequorin.
2.2. Analysis of Δψ
Membrane potential experiments utilized the HeLa-derived cell
line HeLa-Tat, selected for its high transfection efﬁciency [12]. The
cells weremaintained in Dulbecco's modiﬁed Eagle'smedium (Sigma)
supplemented with 10% fetal calf serum (FCS; Invitrogen), 100 U/ml
penicillin, and 20 U/ml streptomycin (complete DMEM). Cells were
seeded at a density of 75,000 cells/ml onto 35-mmplates, cultured for
24 h, and then transfected with a plasmid expressing either wild-type
p13WT–GFP or mutant p13RQ–GFP using Fugene 6 reagent (Roche).
Eighteen hours after transfection, the cells were incubated with 5 nM
tetramethyl rhodamine methyl ester (TMRM, Molecular Probes) for
30 min at 37 °C in the presence of 20 μg/ml verapamil (Sigma) to
block activity of the multidrug resistance pump and allow efﬁcient
and uniform TMRM loading [13,14]. Culture plates were transferred to
a 37 °C, 5% CO2 incubator attached to a Zeiss LSM510 laser scanning
microscope. Images of the living cells were obtained using a heliumneon (543 nm) laser to excite TMRM and an argon laser (488 nm) to
excite GFP; laser intensity, pinhole aperture, and photomultiplier
parameters were standardized to allow comparable measurements.
The mean ﬂuorescence intensities of GFP and TMRM of individual
cellswerequantitatedusing the Zeiss “Histogram” software tool. At least
100 cells from 4 different randomly selected ﬁelds were measured for
each experimental group. Expression levels of GFP-fusion proteins from
4 independent experiments were normalized to the respective mean
value of ﬂuorescence intensity of p13–GFP, while the mitochondrial
membrane potential values were normalized to the respective mean
value of TMRM ﬂuorescence intensity in control non-transfected cells.
The normalizedGFP ﬂuorescence intensity valueswere used to separate
cells into 5 groups with different levels of p13 expression; mean TMRM
ﬂuorescence values in these expression groups were plotted. Statistical
analysis was carried out using the Student's t-test.
2.3. Analysis of the mitochondrial localization of p13
HeLa-Tat cells were seeded at a density of 75,000 cells/ml onto 35-
mm plates, cultured for 24 h, and then transfected with a pSG plasmid
expressing either wild-type (pSGp13) or mutant (pSGp13RQ) p13 using
Fugene 6 reagent (Roche). Twenty-four hours after transfection, the cells
were washed in DMEM and ﬁxed in 3.7% formaldehyde in complete
DMEM for 20min. Cellswere permeabilized in 0.1%Nonidet P-40-PBS for
10 min, washed twice with PBS, and incubated for 45 min at 37 °C with
rabbit polyclonal anti-p13 and goat anti-Hsp60 (Santa Cruz), a
mitochondrial protein used as marker of mitochondrial localization.
After twowasheswith PBS, cells were incubated for 30min at 37 °Cwith
Alexa 488-conjugated anti-rabbit antibody and Alexa 546-conjugated
anti-goat antibody (Molecular Probes). After two washes with PBS,
ﬂuorescent signals were analyzed by laser scanning microscopy using
argon (488 nm) and helium neon (543 nm) lasers sources to excite the
Alexa 488 andAlexa 646 ﬂuorochromes, respectively. Imageswere taken
with a 63× objective at an optical slice of 1 μm. Approximately 30 cells
from 4 different randomly selected ﬁelds were measured for each
experimental group. Expression levels of p13 proteins from 2 indepen-
dent experiments were normalized to the respective mean value of
ﬂuorescence intensity of p13. By using the Zeiss Histogram software, the
colocalization indexes between the two signals (which are detected in
channels 1 and 2 for Hsp60 and p13, respectively) were calculated for
single cells. The colocalization index 1 (CI1) expresses a measure of the
mitochondrial “ﬁlling” with p13 and is the relative number of the
colocalizing p13-Hsp60 pixels, as compared to the total number of Hsp60
pixels above threshold. Colocalization index 2 (CI2), which indicates the
mitochondrial localization of p13, is the ratio between the colocalizing
p13-Hsp60 pixels and the total number of p13 pixels above threshold.
The CI values can range between 0 and 1, according to increasing levels of
colocalization between the pixels of the two channels (channel
1=Hsp60, channel 2=p13; CI=0=no colocalization; CI=1=100%
colocalization). CI1 and CI2 were calculated according to the following
formulas: CI1=pixelsCh1coloc/pixelsCh11total; CI2=pixelsCh2coloc/pixels-
Ch2total. The normalized p13 ﬂuorescence intensity values were used to
separate cells into 4 groupswith different levels of p13 expression;mean
CI values in these expression groupswereplottedon the y-axis. Statistical
analysis was carried out using the Student's t-test.
2.4. Analysis of Ca2+ homeostasis
HeLa cells, maintained in complete DMEM, were seeded onto 13-
mm glass coverslips, grown to 50% conﬂuence, and transfected by
calcium phosphate coprecipitation. Transfection mixtures contained
3 μg of a pSGp13 plasmid expressing wild-type or mutant p13 or a
control plasmid expressing mitochondrial-targeted GFP (mtGFP [15])
and 1 μg of a plasmid expressing mtAEQmut, cytAEQ, or erAEQmut.
For cytosolic and mitochondrial Ca2+ measurements, transfected
HeLa cells were incubated with 5 μM coelenterazine for 1.5 h in
947R. Biasiotto et al. / Biochimica et Biophysica Acta 1797 (2010) 945–951DMEM supplemented with 1% FCS and transferred to the lumin-
ometer perfusion chamber. To efﬁciently reconstitute erAEQmut, the
luminal [Ca2+] of the ERwas reduced by incubating cells for 1 h at 4 °C
inmodiﬁed Krebs-Ringer Buffer (KRB, containing 125 mMNaCl, 5 mM
KCl, 1 mM MgSO4, 1 mM Na2HPO4, 5.5 mM glucose, and 20 mM
HEPES) supplemented with 5 μM coelenterazine, 5 μM ionomycin
(Sigma), and 600 μM EGTA. Cells were then extensively washed with
KRB supplemented with 2% bovine serum albumin (BSA) and 1 mM
EGTA and transferred to the luminometer perfusion chamber. All
aequorin measurements were performed in KRB supplemented with
1 mM CaCl2. Histamine (100 μM)was used as an agonist. To discharge
the residual aequorin pool and calibrate the signal, cells were
lysed with 100 μM digitonin in a hypotonic Ca2+-rich solution
(10 mM CaCl2 in H2O). The aequorin luminescence data were
converted to [Ca2+] values using a computer algorithm based on the
Ca2+ response curve of wild-type and mutant aequorins as described
previously [11]. Results were expressed as means ± standard error
and analyzed for statistical signiﬁcance using the Student's t-test.
3. Results and discussion
3.1. Effects of p13 on Δψ
In previous studies carried out using isolated mitochondria, we
demonstrated that p13 induces a K+ inﬂux resulting in depolarization
and increased ROS production; these alterations in turn lower the
opening threshold of the permeability transition pore [10]. These
effects were dependent on the presence of four arginines (22, 25, 29,
and 30) in the functional α-helical domain spanning amino acids 21–
31 [9,10].
In the present work, we tested the effects of p13 in living cells by
employing plasmids expressing GFP-tagged wild-type p13 (p13WT–
GFP) or a mutant of p13 in which the critical arginines were
substituted with glutamines (p13RQ–GFP). Δψ was measured using
tetramethyl rhodamine methyl ester (TMRM), a ﬂuorescent lipophilic
cation that accumulates in the mitochondrial matrix in a Δψ-
dependent manner. The ﬂuorescence intensity of TMRM in individual
p13-expressing cells (i.e., those with a GFP signal) was measured
using laser scanning microscopy. To conﬁrm the potential-dependent
staining of TMRM, cells were incubated with 1 μM FCCP, a proto-
nophore that collapses the Δψ. This treatment resulted in a loss of
TMRM ﬂuorescence, thus conﬁrming the probe's dependence on Δψ
and indicating that the assay was carried out below its quenching
threshold (data not shown).
Fig. 1 shows a quantitative analysis of the effects of p13 on Δψ in
cells expressing various levels of the protein, measured as GFP
ﬂuorescence intensity: panels A and B show TMRM-labeled cells with
low-intermediate levels of p13WT–GFP and p13RQ–GFP, respectively,
and panels C and D show cells expressing higher levels of the proteins.
The tables on the right-hand side of the ﬁgure report the mean
ﬂuorescence intensities of GFP and TMRM in all the cells analyzed in
the images (indicated by numbers). The scatter plots show TMRM
ﬂuorescence intensity (y-axis) and GFP ﬂuorescence intensity (x-axis)
measured within a single cell, indicated by a white line. Cells
expressing low to intermediate levels of p13WT–GFP varied in
terms of Δψ, while cells expressing p13RQ–GFP invariably maintained
Δψ (see tables in panels A and B); these observations indicated that
p13 was essential but not sufﬁcient for depolarization and suggested
that its function might be subjected to regulation. Future studies will
be aimed at investigating this possibility. In contrast, cells expressing
high levels of p13WT–GFP (panel C) exhibited a marked reduction in
TMRM. No reduction in TMRM ﬂuorescence was observed in cells
expressing high levels of p13RQ–GFP (panel D).
The effect of p13–GFP on Δψ in living cells was further analyzed
using data collected from 4 independent experiments, with at least
100 cells expressing p13WT–GFP or p13RQ–GFP at different levelsanalyzed in each experiment. TMRM signals measured in cells
expressing p13WT–GFP or p13RQ–GFP were scaled against the
mean TMRM ﬂuorescence intensity measured in non-transfected
cells (i.e., cells without a detectable GFP signal), and ﬂuorescence
intensity values measured for p13RQ–GFP were scaled against the
mean ﬂuorescence intensity of p13WT–GFP.
In Fig. 2A, normalized GFP ﬂuorescence intensity values were used
to separate cells into 5 groups with different levels of p13 expression,
and mean TMRM ﬂuorescence values for each group were plotted.
This analysis revealed that cells expressing lower levels of p13WT–
GFP exhibited mean Δψ values similar to those recorded in cells
expressing comparable levels of p13RQ–GFP. However, as p13
expression levels increased, Δψ progressively diminished. In contrast,
no signiﬁcant change in Δψ was observed as p13RQ–GFP levels
increased. Statistical analysis demonstrated highly signiﬁcant differ-
ences inΔψ betweenwild-type andmutant p13 expressing cells in the
intermediate (1.5–1.99 expression group; p=0.0063) and high
expression groups (≥2 expression group; p=2.92×10−6).
As shown in Fig. 2B, the mean values of TMRM ﬂuorescence of the
wild-type vs. mutant p13-expressing cells were signiﬁcantly different
even after pooling all data irrespective of expression levels
(p=4.28×10−5). The mean expression level of p13RQ–GFP was
slightly lower than that of p13WT–GFP, but this difference was not
statistically signiﬁcant (data not shown).
Taken together, these observations indicated that the effect of p13
on Δψ in living cells might be dose-dependent as observed in previous
assays carried out using synthetic p13 and isolated mitochondria [10].
3.2. Intracellular targeting of WT vs. mutant p13
To determine whether the lack of effect of p13RQ–GFP expression
on Δψmight be due to defective mitochondrial targeting compared to
the wild-type protein, we analyzed the colocalization of p13WT and
p13RQ with Hsp60 used as a marker of the mitochondrial compart-
ment (Fig. 3). Results were analyzed by calculating “colocalization
indexes” (CI) indicating the fraction of the p13 (wild-type or mutant)
localized in mitochondria (CI2, panel A) and the fraction of
mitochondrial pixels (i.e., Hsp60) that are also positive for p13 (CI1,
panel B). Results showed that the mutant p13RQ was more efﬁciently
targeted to mitochondria than p13WT (panel A) and that the
mitochondrial compartment presented a similar “ﬁlling” with
p13RQ compared to p13WT (panel B), suggesting that the lack of
effect of p13RQ on Δψ was not due to a reduced mitochondrial
targeting. As shown in Fig. 3C, the overall expression levels of wild-
type vs. mutant p13 were comparable.
3.3. Effects of p13 on Ca2+ uptake by mitochondria
Δψ drives mitochondrial uptake of Ca2+ through the Ca2+
uniporter, a high-afﬁnity Ca2+ channel located in the innermembrane
[16] and/or via the ‘rapid uptake mode’ [17]. Ca2+ uptake by
mitochondria spatially and temporally conﬁnes elevated cytosolic
Ca2+ concentrations, which arise through mobilization of Ca2+ from
the endoplasmic reticulum (ER) via triggering of the IP3 and
ryanodine receptors and by entry from the extracellular medium
through plasma membrane channels. The amplitude, number, and
duration of cytosolic Ca2+ transients constitute a complex signaling
pathway that controls a vast number of biological responses ranging
from muscle contraction to secretion, control of transcription, and
apoptosis. As mitochondrial Ca2+ uptake is known to be driven by Δψ
[18], we next investigated whether p13-induced mitochondrial
depolarization affects mitochondrial Ca2+ homeostasis. This was
tested by transfecting HeLa cells with wild-type p13, a panel of p13
argininemutants (p13RQ, p13RP, p13RAL), or mitochondrial-targeted
GFP (serving as a control mitochondrial protein) together with an
aequorin probe targeted to the mitochondria. After aequorin
Fig. 1. Effects of p13 on Δψ in cells. HeLa-Tat cells were transfected with p13WT–GFP or p13RQ–GFP. Eighteen hours later, cells were incubated with 5 nM TMRM and 20 μg/ml
verapamil for 30 min, and ﬂuorescence intensities of TMRM and GFP were detected by laser scanning microscopy and analyzed as described in Materials and methods. Images show
the GFP, TMRM, and overlay signals (20× magniﬁcation). The scatter plot shows TMRM ﬂuorescence intensity plotted against GFP ﬂuorescence intensity measured in the cell
selected by the white line. Tables report GFP and TMRM ﬂuorescence measured in the numbered cells.
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agonist that acts on G-coupled receptor resulting in inositol 1,4,5
triphosphate (IP3) production and Ca2+ release from intracellular
stores. This assay was performed 3 times, with results assessed by
measuring the Ca2+ peak amplitude.
As shown in Fig. 4A, p13WT caused a mean 56% reduction in the
mitochondrial Ca2+ peak amplitude compared to the control (peak
amplitude: p13WT=27±4 μM; control=62±3 μM; p=3×10−6).
In contrast, the arginine mutants p13RQ and p13RAL did notsigniﬁcantly affect mitochondrial Ca2+ uptake (peak amplitude:
p13RQ=69±4 μM; p13RAL=63±4 μM). p13RP produced a modest
but statistically signiﬁcant increase in mitochondrial Ca2+ content
(peak amplitude: p13RP=74±5 μM, p=0.04).
To investigate whether p13's effects on mitochondrial Ca2+
content could also inﬂuence cytosolic [Ca2+] or could be dependent
on a change in Ca2+ release from the ER, we measured the effects of
p13 on cytosolic and ER [Ca2+] using aequorins targeted to these
compartments. Results of 3 independent experiments showed that
Fig. 2. Δψ in p13-expressing cells. Panel A shows TMRM ﬂuorescence plotted against p13 expression ranges, normalized as indicated in Materials and methods. The data were
obtained from the analysis of 487 p13WT–GFP and 409 p13RQ–GFP cells. The asterisks indicate a signiﬁcant difference calculated by the Student's t-test. In protein expression level
group 0–0.49, p=0.8222; group 0.5–1, p=0.8942; group 1–1.5, p=0.0744; group 1.5–1.99, p=0.0063, and group N2=2.926×10−6. The plot in panel B was generated with data
pooled from all analyzed cells. Δψ is represented as the ratio between the ﬂuorescence intensity (FI) of TMRM in p13WT- or p13RQ-expressing cells and the TMRM mean
ﬂuorescence intensity in non-transfected cells. Mean normalized values and standard error bars are reported. p=4.28×10−5 (Student's t-test).
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amplitudes: control=2.37±0.07 μM; p13WT=2.30±0.12 μM;
p13RQ=2.54±0.06 μM; p13RP=2.40±0.10 μM; p13RAL=2.22±
0.09 μM).Wild-type p13 and the argininemutants p13RP and p13RAL
did not substantially alter ER Ca2+ ﬁlling (Fig. 4C, steady state:
control=442±13 μM; p13WT=460±27 μM; p13RP=500±20 μM;
p13RAL=489±18 μM), while the glutamine mutant induced slightly
higher ER loading compared to the control (steady state:
p13RQ=520±20 μM, p=0.01).
As depicted in the model in Fig. 5, these results demonstrate that
p13 speciﬁcally reduces mitochondrial Ca2+ uptake; the observation
that the arginine mutants did not inﬂuence mitochondrial Ca2+
uptake strongly suggests that this effect is tightly linked to the abilityFig. 3. Mitochondrial targeting of p13WT and p13RQ. Graphs represent colocalization
indexes CI2 (A) and CI1 (B) as a function of p13 expression levels, calculated as
indicated in Materials and methods. Data were derived from the analysis of 56 and 61
cells expressing p13WT and p13RQ, respectively, from 2 independent experiments.
Asterisks indicate a signiﬁcant difference between the wild-type and the mutant in the
corresponding expression level calculated using Student's t-test. Mean normalized
values and standard error bars are indicated. In panel A, in protein expression level
group 0–0.49, p=1.2×10−4; group 0.5–0.99, p=0.0039; group 1–1.49, p=0.0354;
group N1.5, p=0.0896. In panel B, in protein expression level group 0–0.49, p=0.0042;
group 0.5–0.99, p=0.4732; group 1–1.49, p=0.4294; group N1.5, p=0.0828. In panel
C, p=0.3484.of p13 to induce mitochondrial K+ inﬂux and depolarization. The fact
that p13 did not induce a signiﬁcant overall change in cytosolic Ca2+
concentration suggests that mitochondrial depolarization may inﬂu-
ence cytosolic Ca2+ concentration only locally. It would be interesting
to determine whether p13 affects Ca2+ concentration in close vicinity
to plasma membrane Ca2+ channels. In this case, p13 may inﬂuence
store-operated calcium entry, which is of a crucial importance during
T cell activation. It is also possible that p13's effects on Ca2+
homeostasis might result from the protein's ability to promote
mitochondrial fragmentation [5].
Modulation of Ca2+ signaling pathways is a common mechanism
employed by viruses to maximize dissemination and persistence of
infection, with impingement occurring either through direct binding
to Ca2+, modiﬁcation of membrane permeability, or alteration of the
activity of individual signaling components (e.g., channels, pumps,
chaperones, Ca2+ sensors, transcription factors) [19,20].
The effects of p13 on Ca2+ signaling could be particularly relevant
in the context of T cells, the natural target of HTLV-1 infection, as
functional mitochondria are essential for efﬁcient activation through
engagement of the T cell receptor complex [21–23]. Mitochondria
could also play a role during cell-to-cell transmission of HTLV-1
through the “virological synapse”, as it was recently demonstrated
that mitochondria are redistributed to the contact points between the
infected ‘donor’ cell and the target cell [24]. This possibility would be
consistent with the ﬁnding that p13 is essential for viral propagation
in vivo, as suggested by results of studies in a rabbit model [25]. The
results of the Ca2+ uptake assays provide a mechanistic explanation
for the effect of p13 on Ca2+-dependent CREB phosphorylation
reported in a previous study [8]. Consistent with these ﬁndings, HTLV-
1 infection was shown to lead to an alteration in intracellular Ca2+
levels leading to changes in the expression of Ca2+-related genes [26].
p13's ability to increasemitochondrial K+ permeability and in turn
inﬂuence mitochondrial Δψ and Ca2+ homeostasis depends on the
integrity of its amphipathic α-helix. This property, together with its
propensity to form high-molecular weight complexes [9], suggests
that p13 may function as a viroporin. Viroporins are small viral
proteins that contain transmembrane amphipathic α-helical domains
whose multimerization in the context of membranes results in the
formation of channel-like structures. One interesting example of a
viroporin is p7 of hepatitis C virus (HCV), a 63-amino-acid protein
that accumulates primarily in the ER [27]. p7 is necessary for both
Fig. 4. Measurement of Ca2+ content in mitochondria (MT), cytosol (CYT), and endoplasmic reticulum (ER) of p13-expressing cells. [Ca2+] in mitochondria (A), cytosol (B), and
endoplasmic reticulum (C) of HeLa cells expressing control (mtGFP), p13WT, or p13-arginine mutants (p13RQ, p13RP, p13RAL) was analyzed using aequorin probes as described in
Materials and methods. After aequorin reconstitution, cells were challenged with 100 μMhistamine, as indicated in the graphs. The traces show resulting measurements of [Ca2+] as
a function of time and are representative of 3 independent experiments.
Fig. 5. Model of p13's effects on Δψ and Ca2+ uptake. (A) Under physiological
conditions, Ca2+ released from the cellular stores is taken up by polarized
mitochondria. (B) p13 induces an inward K+ inﬂux into the mitochondrial matrix,
causing depolarization and mitochondrial fragmentation. Both these events impair
mitochondrial Ca2+ uptake. This effect is likely to result in perturbations of intracellular
Ca2+ homeostasis and Ca2+ signaling.
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infection in the chimpanzee model [29]. The functional properties of
p7 are attributed to its ability to form a hexameric cation channel that
shows selectivity for Ca2+ over K+ [30] andwhose activity is inhibited
by amantadine [30–32] and long-alkyl chain iminosugar derivatives
[32].
In a previous study, we showed that the p139–41 peptide (at a
concentration of 5 μM) was able to change permeability to Ca2+ of
isolated mitochondrial in a ruthenium red-independent manner [9],
suggesting that this effect was not mediated through the Ca2+
uniporter. However, more recent studies showed that the full-length
protein was unable to change the permeability of isolated mitochon-
drial to Ca2+ at a concentration (100–200nM) thatwas effective onK+
permeability andΔψ (V. Ciminale, unpublishedobservations). It is thus
likely that the effects of p13 observed in living cells are mediated
through its inﬂuence on mitochondrial Δψ and fragmentation, rather
than through a direct effect on mitochondrial Ca2+ permeability.
It is interesting to point out that another small HTLV-1 accessory
protein, p12, accumulates in the ER and Golgi [3] and interacts with
calnexin and calreticulin, two ER-resident proteins that regulate Ca2+
storage [33,34]. This interaction results in increased Ca2+ release from
the ER and decreases the threshold of T cell activation through NFAT
transcriptional activation. These activities of p12may explain why the
protein is required for optimal viral infectivity in quiescent primary
cells [34]. p12 also displays other interesting properties including
association with the β and γc chains of the interleukin-2 receptor and
the heavy chain of MHC class I [3]; a cleaved form of p12, named p8,
accumulates at the cell surface, where it is recruited to the
immunological synapse and downregulates T cell receptor signaling
[35]. Thus, HTLV-1 expresses proteins that impinge on two major
organelles controlling the Ca2+ signalsome; the possible functional
interplay between p12 and p13 represents an attractive subject of
future studies of HTLV-1 replication and pathogenesis.
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